<?xml version="1.0" encoding="UTF-8"?>
<p id="Par16" class="p">A genetically homogeneous population of spirochetes can dynamically alter gene expression in response to changing environmental conditions. When external stimuli on a bacterial subpopulation randomly trigger expression of genes that induce a state of dormancy, then a persister subpopulation can emerge. Persistence only occurs in a subpopulation of 
 <italic class="italic">Borrelia</italic> cells that faces hostile pressure and is characterized by switching between two phenotypes, i.e. susceptible and persistent. 
 <italic class="italic">Borrelia burgdorferi</italic> has been shown to persist when treated with tetracycline antibiotics [
 <xref ref-type="bibr" rid="CR49" class="xref">49</xref>]. Even though the mechanism of persistence for 
 <italic class="italic">Borrelia</italic> has not yet been described, studies of bacterial persisters in fungi, parasites or viruses with a number of identified pathways and genes have shed light on the mechanism of persister formation and survival. The identified pathways in bacterial persisters could serve as potential targets for the development of new anti-persister drugs. These include, for example, toxin-antitoxin modules (
 <italic class="italic">hipBA</italic>, 
 <italic class="italic">relBE</italic>, 
 <italic class="italic">mazEF</italic>, 
 <italic class="italic">tisAB</italic>, 
 <italic class="italic">mqsR</italic>, 
 <italic class="italic">hhA</italic>, 
 <italic class="italic">hokA</italic>, 
 <italic class="italic">cspD</italic>, 
 <italic class="italic">pasT</italic>), stringent response (
 <italic class="italic">relA</italic>, 
 <italic class="italic">dksA</italic>), DNA repair or protection (
 <italic class="italic">lexA</italic>, 
 <italic class="italic">recA</italic>, 
 <italic class="italic">recB</italic>, 
 <italic class="italic">xerC</italic>, 
 <italic class="italic">xerD</italic>, 
 <italic class="italic">dps</italic>), phosphate metabolism (
 <italic class="italic">phoU</italic>), alternative energy production (
 <italic class="italic">sucB</italic>, 
 <italic class="italic">ubiF</italic>, 
 <italic class="italic">glpD</italic>, 
 <italic class="italic">plsB</italic>, 
 <italic class="italic">tgs1</italic>), anti-oxidative stress or macromolecule degradation (superoxide dismutase, catalase) or signaling pathways (
 <italic class="italic">comE/comC; tnaA</italic>, 
 <italic class="italic">oxyR</italic>, 
 <italic class="italic">flu</italic>, 
 <italic class="italic">pspBC</italic>) (for review see [
 <xref ref-type="bibr" rid="CR95" class="xref">95</xref>]). As 
 <italic class="italic">in vitro</italic> persisters differ from 
 <italic class="italic">in vivo</italic> persisters, a drug that can kill all 
 <italic class="italic">in vitro</italic> persisters is not guaranteed to do so 
 <italic class="italic">in vivo</italic>. Nevertheless, the 
 <italic class="italic">in vitro</italic> persisters may share some common features with 
 <italic class="italic">in vivo</italic> persisters and 
 <italic class="italic">in vitro</italic> persister models should still have significant value in persister studies as surrogates of 
 <italic class="italic">in vivo</italic> persisters. Possible overlap between different persisters can be studied using single-cell techniques or RNA sequencing analysis to determine the expression pattern of genes that are differentially regulated by the pathogen as a survival strategy in response to hostile pressure.
</p>
